Scopus Biopharma Inc (SCPS)

Scopus Biopharma Inc (SCPS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $16,833; returns 1 day +0.0%.

Scopus BioPharma Inc. (SCPS) is a biopharmaceutical company focused on developing transformational therapeutics, capitalizing on scientific and medical discoveries from research and academic institutions. Their lead drug candidate is a targeted immuno-oncology gene therapy for the treatment of multiple cancers.

Groups SCPS belongs to

• Biotechnology
• Biopharmaceutical
• Healthcare
• Clinical Stage Biotech
• Oncology
• Immunotherapy
• Gene Therapy
• Unmet Medical Needs
• Clinical Stage

SCPS financial model: income statement, cash flow and balance sheet